Supported by National Program on Key Basic Research Project(973 Program),No.2015CB554300(to Zhang SY);the Joint Research Program for Emerging Frontier Technology in the Municipal Hospital of Shanghai,China,No.SHDC12015129
AIM To examine the clinical features and risk factors for adverse outcomes in chronic hepatitis B(CHB) superimposed with hepatitis E virus(HEV).METHODS This retrospective cohort study included 228 patients with acute ...
The current work was partially supported by the National Basic Research Program of China(973 Program,no.2011CB505105);We thank Guoyan Yang from National Institute of Complementary Medicine,University of Western Medicine for her suggestions in data synthesis.
Objective:To systematically evaluate the effectiveness and safety of Chinese herbal medicine (CHM) plus nucleotide analogues (NAs) for treating compensated HBV-related cirrhosis,the early stage of cirrhosis.Methods:Pu...
supported by the Capital Medical Development Foundation(Grant No.2011-2015-02);the National Basic Research Program of China (973 Program)(Grant No.2011CB707705);the Capital Characteristic Clinical Application Research(Grant No.Z121107001012115)
Objective: To assess if diffusion-weighted magnetic resonance (MR) imaging without apparent diffusion coefficient (ADC) values provides added diagnostic value in combination with conventional MR imaging in the de...